APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glutamate Receptor Ionotropic NMDA 2B

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Glutamate Receptor Ionotropic NMDA 2B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025184 pages

Choose your research edition.

Industry ResearchGlutamate Receptor Ionotropic NMDA 2B Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Glutamate Receptor Ionotropic NMDA 2B Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Glutamate Receptor Ionotropic NMDA 2B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glutamate Receptor Ionotropic NMDA 2B Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Glutamate Receptor Ionotropic NMDA 2B Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Glutamate Receptor Ionotropic NMDA 2B market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Glutamate Receptor Ionotropic NMDA 2B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glutamate Receptor Ionotropic NMDA 2B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glutamate Receptor Ionotropic NMDA 2B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Glutamate Receptor Ionotropic NMDA 2B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glutamate Receptor Ionotropic NMDA 2B include Johnson & Johnson, Novartis AG, UCB S.A., NeurOp, Inc, Luc Therapeutics, Inc., Cerecor Inc., Bristol-Myers Squibb Company and BioCrea GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glutamate Receptor Ionotropic NMDA 2B market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glutamate Receptor Ionotropic NMDA 2B and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glutamate Receptor Ionotropic NMDA 2B sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glutamate Receptor Ionotropic NMDA 2B market size, projected growth trends, production technologies, key applications, and end-use industries.

Glutamate Receptor Ionotropic NMDA 2B Segment by Company

Johnson & Johnson

Novartis AG

UCB S.A.

NeurOp, Inc

Luc Therapeutics, Inc.

Cerecor Inc.

Bristol-Myers Squibb Company

BioCrea GmbH

Glutamate Receptor Ionotropic NMDA 2B Segment by Type

JNJ-0808

Radiprodil

NP-11948

NP-10679

Neu-2000

Others

Glutamate Receptor Ionotropic NMDA 2B Segment by Application

Burns

Acute Ischemic Stroke

Brain Ischemia

Autism

Others

Glutamate Receptor Ionotropic NMDA 2B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glutamate Receptor Ionotropic NMDA 2B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glutamate Receptor Ionotropic NMDA 2B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glutamate Receptor Ionotropic NMDA 2B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glutamate Receptor Ionotropic NMDA 2B market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glutamate Receptor Ionotropic NMDA 2B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Glutamate Receptor Ionotropic NMDA 2B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Glutamate Receptor Ionotropic NMDA 2B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Glutamate Receptor Ionotropic NMDA 2B Industry Trends Table 2. Glutamate Receptor Ionotropic NMDA 2B Industry Drivers Table 3. Glutamate Receptor Ionotropic NMDA 2B Industry Opportunities and Challenges Table 4. Glutamate Receptor Ionotropic NMDA 2B Industry Restraints Table 5. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers Table 9. Global Glutamate Receptor Ionotropic NMDA 2B Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Glutamate Receptor Ionotropic NMDA 2B Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Glutamate Receptor Ionotropic NMDA 2B Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers, Product Type & Application Table 13. Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Glutamate Receptor Ionotropic NMDA 2B by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of JNJ-0808 Table 17. Major Manufacturers of Radiprodil Table 18. Major Manufacturers of NP-11948 Table 19. Major Manufacturers of NP-10679 Table 20. Major Manufacturers of Neu-2000 Table 21. Major Manufacturers of Others Table 22. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 24. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2027-2032) & (W Units) Table 25. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2021-2026) Table 26. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2027-2032) Table 27. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 28. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2026) & (W Units) Table 29. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2027-2032) & (W Units) Table 30. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2021-2026) Table 31. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Burns Table 33. Major Manufacturers of Acute Ischemic Stroke Table 34. Major Manufacturers of Brain Ischemia Table 35. Major Manufacturers of Autism Table 36. Major Manufacturers of Others Table 37. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 39. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2027-2032) & (W Units) Table 40. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2021-2026) Table 41. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2027-2032) Table 42. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 43. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2026) & (W Units) Table 44. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2027-2032) & (W Units) Table 45. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2021-2026) Table 46. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2027-2032) Table 47. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 48. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021-2026) & (W Units) Table 49. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2021-2026) Table 50. Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecasted by Region (2027-2032) & (W Units) Table 51. Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 54. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2027-2032) & (W Units) Table 55. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 57. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2027-2032) & (W Units) Table 58. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 60. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2027-2032) & (W Units) Table 61. South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 62. South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 63. South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2027-2032) & (W Units) Table 64. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2021-2026) Table 68. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2027-2032) Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 78. Novartis AG Recent Development Table 79. UCB S.A. Company Information Table 80. UCB S.A. Business Overview Table 81. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 83. UCB S.A. Recent Development Table 84. NeurOp, Inc Company Information Table 85. NeurOp, Inc Business Overview Table 86. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 88. NeurOp, Inc Recent Development Table 89. Luc Therapeutics, Inc. Company Information Table 90. Luc Therapeutics, Inc. Business Overview Table 91. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 93. Luc Therapeutics, Inc. Recent Development Table 94. Cerecor Inc. Company Information Table 95. Cerecor Inc. Business Overview Table 96. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 98. Cerecor Inc. Recent Development Table 99. Bristol-Myers Squibb Company Company Information Table 100. Bristol-Myers Squibb Company Business Overview Table 101. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 103. Bristol-Myers Squibb Company Recent Development Table 104. BioCrea GmbH Company Information Table 105. BioCrea GmbH Business Overview Table 106. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 108. BioCrea GmbH Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Glutamate Receptor Ionotropic NMDA 2B Distributors List Table 112. Glutamate Receptor Ionotropic NMDA 2B Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Glutamate Receptor Ionotropic NMDA 2B Product Image Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (2021-2032) & (US$ Million) Figure 4. Global Glutamate Receptor Ionotropic NMDA 2B Sales (2021-2032) & (W Units) Figure 5. Global Glutamate Receptor Ionotropic NMDA 2B Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Glutamate Receptor Ionotropic NMDA 2B Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. JNJ-0808 Image Figure 9. Radiprodil Image Figure 10. NP-11948 Image Figure 11. NP-10679 Image Figure 12. Neu-2000 Image Figure 13. Others Image Figure 14. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2021-2032) Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2021-2032) Figure 20. Burns Image Figure 21. Acute Ischemic Stroke Image Figure 22. Brain Ischemia Image Figure 23. Autism Image Figure 24. Others Image Figure 25. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2021-2032) Figure 28. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 29. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2021-2032) Figure 31. North America Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 32. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2021-2032) Figure 33. U.S. Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Canada Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Mexico Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2021-2032) Figure 38. Germany Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 39. France Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 40. U.K. Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Italy Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Netherlands Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2021-2032) Figure 45. China Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Japan Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South Korea Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 49. India Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Australia Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 52. South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2021-2032) Figure 53. Brazil Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 54. South Africa Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Turkey Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Argentina Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 58. UAE Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Egypt Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Chile Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2021-2032) & (W Units) Figure 61. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Figure 64. North America Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Figure 66. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Glutamate Receptor Ionotropic NMDA 2B Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • JNJ-0808
  • Radiprodil
  • NP-11948
  • NP-10679
  • Neu-2000
  • Others
Applications
  • Burns
  • Acute Ischemic Stroke
  • Brain Ischemia
  • Autism
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • UCB S.A.
  • NeurOp, Inc
  • Luc Therapeutics, Inc.
  • Cerecor Inc.
  • Bristol-Myers Squibb Company
  • BioCrea GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Glutamate Receptor Ionotropic NMDA 2B Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Glutamate Receptor Ionotropic NMDA 2B Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
  1. 2.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
  2. 2.2 Glutamate Receptor Ionotropic NMDA 2B Industry Drivers
  3. 2.3 Glutamate Receptor Ionotropic NMDA 2B Industry Opportunities and Challenges
  4. 2.4 Glutamate Receptor Ionotropic NMDA 2B Industry Restraints
3 Glutamate Receptor Ionotropic NMDA 2B Market by Manufacturers
  1. 3.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers (2021-2026)
  3. 3.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Glutamate Receptor Ionotropic NMDA 2B Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glutamate Receptor Ionotropic NMDA 2B Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers, Product Type & Application
  7. 3.7 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glutamate Receptor Ionotropic NMDA 2B Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glutamate Receptor Ionotropic NMDA 2B Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glutamate Receptor Ionotropic NMDA 2B Tier 1, Tier 2, and Tier 3
4 Glutamate Receptor Ionotropic NMDA 2B Market by Type
  1. 4.1 Glutamate Receptor Ionotropic NMDA 2B Type Introduction
  2. 4.1.1 JNJ-0808
  3. 4.1.2 Radiprodil
  4. 4.1.3 NP-11948
  5. 4.1.4 NP-10679
  6. 4.1.5 Neu-2000
  7. 4.1.6 Others
  8. 4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type
  9. 4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2032)
  11. 4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2021-2032)
  12. 4.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type
  13. 4.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2032)
  15. 4.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2021-2032)
5 Glutamate Receptor Ionotropic NMDA 2B Market by Application
  1. 5.1 Glutamate Receptor Ionotropic NMDA 2B Application Introduction
  2. 5.1.1 Burns
  3. 5.1.2 Acute Ischemic Stroke
  4. 5.1.3 Brain Ischemia
  5. 5.1.4 Autism
  6. 5.1.5 Others
  7. 5.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application
  8. 5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2032)
  10. 5.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2021-2032)
  11. 5.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application
  12. 5.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2032)
  14. 5.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2021-2032)
6 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region
  1. 6.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021-2032)
  3. 6.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021-2026)
  4. 6.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region
  1. 7.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region
  2. 7.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2021-2026)
  4. 7.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2027-2032)
  5. 7.1.4 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032)
  8. 7.2.2 North America Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032)
  11. 7.3.2 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 UCB S.A.
  14. 8.3.1 UCB S.A. Company Information
  15. 8.3.2 UCB S.A. Business Overview
  16. 8.3.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  18. 8.3.5 UCB S.A. Recent Developments
  19. 8.4 NeurOp, Inc
  20. 8.4.1 NeurOp, Inc Company Information
  21. 8.4.2 NeurOp, Inc Business Overview
  22. 8.4.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  24. 8.4.5 NeurOp, Inc Recent Developments
  25. 8.5 Luc Therapeutics, Inc.
  26. 8.5.1 Luc Therapeutics, Inc. Company Information
  27. 8.5.2 Luc Therapeutics, Inc. Business Overview
  28. 8.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  30. 8.5.5 Luc Therapeutics, Inc. Recent Developments
  31. 8.6 Cerecor Inc.
  32. 8.6.1 Cerecor Inc. Company Information
  33. 8.6.2 Cerecor Inc. Business Overview
  34. 8.6.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  36. 8.6.5 Cerecor Inc. Recent Developments
  37. 8.7 Bristol-Myers Squibb Company
  38. 8.7.1 Bristol-Myers Squibb Company Company Information
  39. 8.7.2 Bristol-Myers Squibb Company Business Overview
  40. 8.7.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  42. 8.7.5 Bristol-Myers Squibb Company Recent Developments
  43. 8.8 BioCrea GmbH
  44. 8.8.1 BioCrea GmbH Company Information
  45. 8.8.2 BioCrea GmbH Business Overview
  46. 8.8.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  48. 8.8.5 BioCrea GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glutamate Receptor Ionotropic NMDA 2B Value Chain Analysis
  2. 9.1.1 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process
  6. 9.2 Glutamate Receptor Ionotropic NMDA 2B Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
  9. 9.2.3 Glutamate Receptor Ionotropic NMDA 2B Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst